New CDK strategies could target tumor growth by shutting down key gene activity
Cancer is the second-leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus. This family of enzymes plays a fundamental role in gene expression and cell division. An overview of the current state of research on the transcriptional regulation…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
